X Zong, Z Yang, J Zhou, Z Jin, D Wu - Frontiers in Immunology, 2024 - frontiersin.org
Background Angioimmunoblastic T-cell lymphoma (AITL) is known for its unfavorable
survival prognosis. Chidamide has shown efficacy in relapsed/refractory AITL, but its efficacy …